written on 08.05.2014
Tags:
,

Lundbeck makes $658M bid for Chelsea, gaining once-rejected dizziness drug Northera

TAGS: ,

One day after announcing a drop in quarterly sales and profits, Danish drugmaker Lundbeck said it will pick up Chelsea Therapeutics for cash and contingent value rights in a deal worth up to $658 million.

Latest Report